CAR T-Cell Therapy and the Pharmacology of Managing Cytokine Release Syndrome
Presented by Jae Park, MD, and Amber C. King, PharmD, BCOP
Memorial Sloan Kettering Cancer Center, New York, New York
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2019;10(3):212–215 |
© 2019 Harborside™
Jae Park, MD, and Amber C. King, PharmD, BCOP, shared background and clinical information regarding CAR T-cell therapy in acute lymphoblastic leukemia and large-cell lymphoma, as well as strategies to mitigate cytokine release syndrome and other serious side effects of therapy.
For access to the full length article, please sign in